|
Posting date: October 29, 2003 Copyright © 2003 by Project HOPE
Prices And Availability Of Pharmaceuticals: Evidence From Nine Countries
1 Patricia Danzon is the Celia Moh Professor in the Wharton School's Health Care Department, University of Pennsylvania, in Philadelphia.
*Corresponding author.
This study compares average price levels for pharmaceuticals in eight countries--Canada, Chile, France, Germany, Italy, Japan, Mexico, and United Kingdom--relative to the United States. Our most comprehensive indexes, adjusted for U.S. manufacturer discounts, show Japan’s prices higher than U.S. prices, and other countries’ prices ranging from 6 percent to 33 percent lower than U.S. prices. The decline of the Canadian dollar and rise of the U.K. pound contribute to the finding of lower Canadian prices and higher U.K. prices in 1999 than in 1992. Our findings suggest that U.S.-foreign price differentials are smaller for drugs than for other medical services. Key Words: International Issues, Health Spending, Pharmaceuticals
This article has been cited by other articles:
| |||||||||||||||||||||||||||
